$XTALPI(02228.HK) Last night, I seriously listened to the in-depth conversation between Jensen Huang (NVIDIA) and David Ricks (Eli Lilly CEO), announcing a top-tier AI + pharmaceutical collaboration. The goal is to transform drug development from a "game of chance" into a predictable engineering science. Designing drugs like designing chips, using AI modeling + federated learning (NVFlare) + robotic wet labs to achieve full-process acceleration, precise prediction, and secure data collaboration. Jingtai is ahead of the curve, and industry leaders are already rushing in. The question is whether it can maintain its lead!